Werkgroep Cardiologische centra Nederland

COMPASS-LTOLE (Follow-up)

A randomized controlled trial of rivaroxaban for the prevention of cardiovascular events in patients with coronary or peripheral artery disease
Medicine
rivaroxaban
Population
ASCVD
Phase
III
Starting year
2018